These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3902429)
1. Flecainide: a new class Ic antidysrhythmic. Smith GH Drug Intell Clin Pharm; 1985 Oct; 19(10):703-7. PubMed ID: 3902429 [TBL] [Abstract][Full Text] [Related]
2. Flecainide: a new prototype antiarrhythmic agent. Nappi JM; Anderson JL Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035 [TBL] [Abstract][Full Text] [Related]
4. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Holmes B; Heel RC Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390 [TBL] [Abstract][Full Text] [Related]
5. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial. Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110 [TBL] [Abstract][Full Text] [Related]
6. A proposal for the clinical use of flecainide. Anderson JL; Stewart JR; Crevey BJ Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767 [TBL] [Abstract][Full Text] [Related]
7. Flecainide versus quinidine: results of a multicenter trial. Hodges M; Salerno DM; Granrud G Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770 [TBL] [Abstract][Full Text] [Related]
8. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749 [TBL] [Abstract][Full Text] [Related]
9. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. Morganroth J; Horowitz LN Am J Cardiol; 1984 Feb; 53(5):89B-94B. PubMed ID: 6695821 [TBL] [Abstract][Full Text] [Related]
10. Flecainide: a new agent for the treatment of ventricular arrhythmias. Grubb BP; Tilley-Gray B Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958 [TBL] [Abstract][Full Text] [Related]
11. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656 [TBL] [Abstract][Full Text] [Related]
18. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. Kjekshus J; Bathen J; Orning OM; Storstein L Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140 [TBL] [Abstract][Full Text] [Related]
19. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics. Perry JC; McQuinn RL; Smith RT; Gothing C; Fredell P; Garson A J Am Coll Cardiol; 1989 Jul; 14(1):185-91; discussion 192-3. PubMed ID: 2500470 [TBL] [Abstract][Full Text] [Related]
20. Oral flecainide acetate for the treatment of ventricular arrhythmias. Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]